Submitted by Anonymous (not verified) on 5 February 2025 - 10:06
Human medicines European public assessment report (EPAR): Enyglid, repaglinide, Date of authorisation: 13/10/2009, Revision: 10, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Enyglid, repaglinide, Date of authorisation: 13/10/2009, Revision: 10, Status: Authorised